The GRADE Working Group clarifies the construct of certainty of evidence

Balshem, 2011, GRADE guidelines: 3. Rating the quality of evidence, J Clin Epidemiol, 64, 401, 10.1016/j.jclinepi.2010.07.015 Guyatt, 2011, GRADE guidelines 6. Rating the quality of evidence–imprecision, J Clin Epidemiol, 64, 1283, 10.1016/j.jclinepi.2011.01.012 Welch, 2017, GRADE Equity Guidelines 3: health equity considerations in rating the certainty of synthesized evidence, J Clin Epidemiol Schunemann, 2016, Interpreting GRADE's levels of certainty or quality of the evidence: GRADE for statisticians, considering review information size or less emphasis on imprecision?, J Clin Epidemiol, 75, 6, 10.1016/j.jclinepi.2016.03.018 Schunemann, 2011, Guidelines 2.0: do no net harm-the future of practice guideline development in asthma and other diseases, Curr Allergy Asthma Rep, 11, 261, 10.1007/s11882-011-0185-8 Spencer, 2015, Longer- versus shorter-duration dual-antiplatelet therapy after drug-eluting stent placement: a systematic review and meta-analysis, Ann Intern Med, 163, 118, 10.7326/M15-0083 Guyatt, 2013, GRADE guidelines: 11. Making an overall rating of confidence in effect estimates for a single outcome and for all outcomes, J Clin Epidemiol, 66, 151, 10.1016/j.jclinepi.2012.01.006 Andrews, 2013, GRADE guidelines: 15. Going from evidence to recommendation-determinants of a recommendation's direction and strength, J Clin Epidemiol, 66, 726, 10.1016/j.jclinepi.2013.02.003 MacLean, 2012, Patient values and preferences in decision making for antithrombotic therapy: a systematic review: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed.: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines, Chest, 141, e1S, 10.1378/chest.11-2290 Darzi, 2016, Stakeholders' perceptions of rehabilitation services for individuals living with disability: a survey study, Health Qual Life Outcomes, 14, 2, 10.1186/s12955-016-0406-x Santesso, 2012, World Health Organization Guidelines: use of cryotherapy for cervical intraepithelial neoplasia, Int J Gynaecol Obstet, 118, 97, 10.1016/j.ijgo.2012.01.029 Schunemann, 2007, Transparent development of the WHO rapid advice guidelines, PLoS Med, 4, e119, 10.1371/journal.pmed.0040119 Puhan, 2012, A framework for organizing and selecting quantitative approaches for benefit-harm assessment, BMC Med Res Methodol, 12, 173, 10.1186/1471-2288-12-173 Yu, 2014, Benefits and harms of roflumilast in moderate to severe COPD, Thorax, 69, 616, 10.1136/thoraxjnl-2013-204155